drugset / Trial / NCT02145104
Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate of efficacy and safety of cilinidipine plus valsartan and valsartan alone in patients with essential hypertension inadequately controlled on valsartan monotherapy
Timeline
- Start
- 2014-06-17
- Primary completion
- 2016-06-07
- Completion
- 2016-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilnidipine | Small molecule | 5 mg | — |
| Subject | Cilnidipine | Small molecule | 10 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |